<DOC>
	<DOCNO>NCT01974128</DOCNO>
	<brief_summary>The intent clinical study answer question : 1 ) Is propose treatment safe ? 2 ) Is treatment effective improve cardiac function clinical outcome ?</brief_summary>
	<brief_title>Study Assess Safety Cardiovascular Effects Autologous Adipose-Derived Stromal Cells Implantation In Patients During Acute Recovery Phase ST-Elevation Myocardial Infarction</brief_title>
	<detailed_description>The primary objective study evaluate patient recover acute myocardial infarction ( &lt; 8 day index infarction ) safety profile intramyocardial ASCs preliminary efficacy ASCs therapy . This open-label , non-randomized patient sponsor multi-center study ASC implantation use catheter delivery system . ASCs derive patient 's adipose-derived tissue . Liposuction perform collect adipose tissue specimen subsequent process isolate stem cell . The injection catheter use delivery ASCs therapy .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Males Females Age 18 80 year . Defined acute myocardial infarction &lt; 8 day screen Left ventricular ejection fraction screen ≤ 50 % , 2 contiguous area severe wall motion abnormality rest echocardiography . Patients must minimum myocardial wall thickness 5mm Need feasibility revascularization rule coronary angiogram noninvasive stress testing . Up date age gender appropriate cancer screen per American Cancer Society Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study Life expectancy &lt; 6 month due concomitant illness . NYHA CHF Class 4 Severe valvular nonischemic myocardial disease . Mechanical complication index acute myocardial infarction include limited rupture mitral valve resultant development mitral regurgitation , rupture leave ventricular free wall rupture interventricular septum . Active infectious disease and/or know test positive HIV , HTLV , HBV , HCV , CMV ( IgM &gt; IgG ) and/or syphilis . If panel include antibody HBVcAg HBVsAg , expert consult patient eligibility base patient 's infectious status Any illness , Investigator 's judgment , interfere patient 's ability comply protocol , compromise patient safety , interfere interpretation study result Patients chronic immunosuppressive transplant therapy Systolic blood pressure ( supine ) ≤90 mmHg ; Resting heart rate &gt; 100 bpm ; Active clinical infection within one week enrollment . Cerebrovascular accident within 6 month prior study entry Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last five year . Unwilling and/or able give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MI</keyword>
</DOC>